Share Price and Basic Stock Data
Last Updated: February 24, 2025, 1:06 pm
PEG Ratio | -8.98 |
---|
Competitors of Supreme Petrochem Ltd
Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
---|---|---|---|---|---|---|---|---|---|
Hindustan Fluoro Carbons Ltd | 27.5 Cr. | 14.0 | 22.6/12.6 | 48.3 | 41.9 | 0.00 % | 3.05 % | % | 10.0 |
Gujarat Petrosynthese Ltd | 38.2 Cr. | 64.0 | 98.0/48.0 | 34.7 | 81.9 | 0.00 % | 2.73 % | 3.46 % | 10.0 |
AVI Polymers Ltd | 5.12 Cr. | 12.5 | 15.0/9.45 | 63.9 | 12.0 | 0.00 % | 0.57 % | 0.41 % | 10.0 |
Supreme Petrochem Ltd | 10,959 Cr. | 584 | 927/556 | 26.4 | 112 | 1.56 % | 22.5 % | 16.8 % | 2.00 |
Signet Industries Ltd | 154 Cr. | 52.8 | 97.4/49.0 | 13.2 | 75.4 | 0.94 % | 14.8 % | 7.22 % | 10.0 |
Industry Average | 3,820.29 Cr | 181.14 | 38.34 | 79.55 | 0.93% | 12.39% | 9.72% | 7.55 |
Quarterly Result
Metric | Sep 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sales | 1,191 | 1,296 | 1,498 | 1,485 | 1,235 | 1,180 | 1,387 | 1,225 | 1,278 | 1,188 | 1,563 | 1,573 | 1,506 |
Expenses | 1,015 | 1,072 | 1,190 | 1,234 | 1,156 | 1,061 | 1,179 | 1,135 | 1,171 | 1,093 | 1,388 | 1,412 | 1,380 |
Operating Profit | 176 | 224 | 307 | 252 | 79 | 119 | 208 | 90 | 106 | 95 | 175 | 161 | 125 |
OPM % | 15% | 17% | 21% | 17% | 6% | 10% | 15% | 7% | 8% | 8% | 11% | 10% | 8% |
Other Income | 5 | 8 | 9 | 12 | 12 | 14 | 21 | 18 | 16 | 16 | 19 | 23 | 17 |
Interest | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 3 | 2 | 3 | 3 |
Depreciation | 11 | 11 | 10 | 11 | 11 | 11 | 14 | 14 | 14 | 15 | 16 | 16 | 17 |
Profit before tax | 168 | 221 | 305 | 252 | 78 | 121 | 215 | 94 | 106 | 92 | 177 | 164 | 122 |
Tax % | 24% | 25% | 26% | 25% | 24% | 26% | 26% | 26% | 26% | 27% | 26% | 26% | 26% |
Net Profit | 127 | 165 | 225 | 189 | 60 | 90 | 159 | 69 | 78 | 68 | 132 | 122 | 90 |
EPS in Rs | 6.76 | 8.75 | 11.99 | 10.06 | 3.18 | 4.78 | 8.47 | 3.68 | 4.15 | 3.60 | 6.99 | 6.49 | 4.80 |
Last Updated: December 26, 2024, 4:43 pm
Profit & Loss - Annual Report
Last Updated: December 26, 2024, 4:43 pm
Metric | Jun 2013 | Jun 2014 | Jun 2015 | Mar 2016n n 9m | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sales | 2,967 | 3,264 | 2,653 | 2,068 | 2,919 | 3,027 | 3,194 | 2,724 | 3,185 | 5,032 | 5,287 | 5,253 | 5,830 |
Expenses | 2,810 | 3,175 | 2,559 | 1,964 | 2,621 | 2,830 | 3,100 | 2,576 | 2,510 | 4,126 | 4,626 | 4,780 | 5,273 |
Operating Profit | 157 | 90 | 93 | 104 | 297 | 196 | 93 | 148 | 675 | 907 | 661 | 473 | 556 |
OPM % | 5% | 3% | 4% | 5% | 10% | 6% | 3% | 5% | 21% | 18% | 12% | 9% | 10% |
Other Income | 4 | 6 | 3 | 3 | 7 | 8 | 10 | 12 | 16 | 30 | 59 | 65 | 74 |
Interest | 24 | 23 | 17 | 5 | 5 | 5 | 4 | 6 | 8 | 7 | 6 | 10 | 11 |
Depreciation | 28 | 29 | 24 | 17 | 22 | 21 | 23 | 36 | 39 | 42 | 47 | 59 | 64 |
Profit before tax | 110 | 44 | 56 | 85 | 278 | 179 | 76 | 118 | 644 | 888 | 667 | 468 | 555 |
Tax % | 34% | 31% | 37% | 33% | 35% | 35% | 35% | 13% | 26% | 25% | 25% | 26% | |
Net Profit | 73 | 31 | 36 | 57 | 179 | 116 | 49 | 103 | 477 | 663 | 498 | 346 | 411 |
EPS in Rs | 3.76 | 1.58 | 1.85 | 2.96 | 9.30 | 6.02 | 2.55 | 5.32 | 25.40 | 35.28 | 26.49 | 18.43 | 21.88 |
Dividend Payout % | 33% | 47% | 41% | 51% | 24% | 37% | 59% | 52% | 30% | 26% | 42% | 49% |
YoY Net Profit Growth
Year | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 |
---|---|---|---|---|---|---|---|
YoY Net Profit Growth (%) | -35.20% | -57.76% | 110.20% | 363.11% | 38.99% | -24.89% | -30.52% |
Change in YoY Net Profit Growth (%) | 0.00% | -22.56% | 167.96% | 252.90% | -324.11% | -63.88% | -5.64% |
Supreme Petrochem Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 7 years from 2017-2018 to 2023-2024.
Growth
Compounded Sales Growth | |
---|---|
10 Years: | 6% |
5 Years: | 10% |
3 Years: | 18% |
TTM: | 19% |
Compounded Profit Growth | |
---|---|
10 Years: | 16% |
5 Years: | 46% |
3 Years: | -12% |
TTM: | 11% |
Stock Price CAGR | |
---|---|
10 Years: | 33% |
5 Years: | 49% |
3 Years: | 20% |
1 Year: | -23% |
Return on Equity | |
---|---|
10 Years: | 27% |
5 Years: | 31% |
3 Years: | 29% |
Last Year: | 17% |
Last Updated: Unknown
Balance Sheet
Last Updated: November 14, 2024, 7:33 pm
Month | Jun 2013 | Jun 2014 | Jun 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Sep 2024 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 97 | 96 | 96 | 96 | 96 | 96 | 96 | 96 | 94 | 38 | 38 | 38 | 38 |
Reserves | 256 | 268 | 280 | 318 | 486 | 549 | 546 | 577 | 971 | 1,478 | 1,806 | 1,982 | 2,062 |
Borrowings | 75 | 32 | 0 | 0 | 0 | 0 | 0 | 29 | 41 | 37 | 17 | 114 | 123 |
Other Liabilities | 601 | 587 | 505 | 523 | 548 | 650 | 578 | 552 | 649 | 725 | 870 | 932 | 772 |
Total Liabilities | 1,028 | 984 | 881 | 938 | 1,130 | 1,296 | 1,221 | 1,255 | 1,755 | 2,278 | 2,731 | 3,065 | 2,995 |
Fixed Assets | 366 | 371 | 345 | 333 | 337 | 333 | 331 | 371 | 359 | 337 | 527 | 769 | 780 |
CWIP | 31 | 4 | 4 | 10 | 13 | 10 | 24 | 8 | 9 | 179 | 108 | 233 | 325 |
Investments | 0 | 0 | 0 | 0 | 0 | 111 | 251 | 135 | 470 | 484 | 563 | 572 | 315 |
Other Assets | 631 | 608 | 532 | 595 | 780 | 842 | 615 | 741 | 917 | 1,279 | 1,534 | 1,492 | 1,576 |
Total Assets | 1,028 | 984 | 881 | 938 | 1,130 | 1,296 | 1,221 | 1,255 | 1,755 | 2,278 | 2,731 | 3,065 | 2,995 |
Cash Flow
Month | Jun 2013 | Jun 2014 | Jun 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
Month | Jun 2013 | Jun 2014 | Jun 2015 | Mar 2016n n 9m | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow | 82.00 | 58.00 | 93.00 | 104.00 | 297.00 | 196.00 | 93.00 | 119.00 | 634.00 | 870.00 | 644.00 | 359.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
Month | Jun 2013 | Jun 2014 | Jun 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 40 | 38 | 33 | 50 | 38 | 36 | 33 | 33 | 44 | 30 | 25 | 27 |
Inventory Days | 31 | 22 | 29 | 37 | 46 | 44 | 31 | 40 | 51 | 29 | 55 | 39 |
Days Payable | 68 | 60 | 61 | 83 | 65 | 80 | 60 | 74 | 90 | 50 | 66 | 66 |
Cash Conversion Cycle | 2 | -0 | 1 | 3 | 19 | -0 | 3 | -0 | 4 | 8 | 14 | 0 |
Working Capital Days | -0 | 1 | 3 | 8 | 22 | 12 | 5 | 6 | 21 | 9 | 20 | 2 |
ROCE % | 31% | 16% | 19% | 22% | 57% | 30% | 12% | 18% | 72% | 66% | 37% | 22% |
Mutual Fund Holdings
Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
---|---|---|---|---|---|---|
HSBC Small Cap Fund - Regular Plan | 3,388,150 | 1.43 | 189.6 | 777,400 | 2025-02-21 | 335.83% |
HSBC Value Fund | 777,400 | 0.4 | 43.5 | 777,400 | 2025-02-21 | 0% |
ICICI Prudential Smallcap Fund | 329,871 | 0.26 | 18.46 | 777,400 | 2025-02-21 | -57.57% |
Motilal Oswal Nifty Microcap 250 Index Fund | 72,039 | 0.65 | 4.03 | 777,400 | 2025-02-21 | -90.73% |
ICICI Prudential S&P BSE 500 ETF | 714 | 0.02 | 0.04 | 777,400 | 2025-02-21 | -99.91% |
HDFC S&P BSE 500 Index Fund | 134 | 0.02 | 0.01 | 777,400 | 2025-02-21 | -99.98% |
HDFC S&P BSE 500 ETF | 28 | 0.02 | 0 | 777,400 | 2025-02-21 | -100% |
Key Financial Ratios
Month | Mar 24 | Mar 23 | Mar 22 | Mar 21 | Mar 20 |
---|---|---|---|---|---|
FaceValue | 2.00 | 2.00 | 4.00 | 10.00 | 10.00 |
Basic EPS (Rs.) | 18.43 | 26.49 | 70.54 | 50.63 | 10.64 |
Diluted EPS (Rs.) | 18.43 | 26.49 | 70.54 | 50.63 | 10.64 |
Cash EPS (Rs.) | 21.59 | 28.97 | 75.00 | 54.95 | 14.38 |
Book Value[Excl.RevalReserv]/Share (Rs.) | 107.38 | 98.06 | 161.20 | 113.26 | 69.81 |
Book Value[Incl.RevalReserv]/Share (Rs.) | 107.38 | 98.06 | 161.20 | 113.26 | 69.81 |
Dividend / Share (Rs.) | 9.00 | 9.00 | 7.20 | 15.00 | 5.50 |
Revenue From Operations / Share (Rs.) | 279.37 | 281.17 | 535.23 | 338.77 | 282.49 |
PBDIT / Share (Rs.) | 28.45 | 38.13 | 99.54 | 73.41 | 16.64 |
PBIT / Share (Rs.) | 25.28 | 35.66 | 95.09 | 69.25 | 12.90 |
PBT / Share (Rs.) | 24.90 | 35.46 | 94.43 | 68.47 | 12.23 |
Net Profit / Share (Rs.) | 18.43 | 26.49 | 70.54 | 50.78 | 10.64 |
PBDIT Margin (%) | 10.18 | 13.56 | 18.59 | 21.66 | 5.88 |
PBIT Margin (%) | 9.05 | 12.68 | 17.76 | 20.44 | 4.56 |
PBT Margin (%) | 8.91 | 12.61 | 17.64 | 20.21 | 4.32 |
Net Profit Margin (%) | 6.59 | 9.42 | 13.18 | 14.99 | 3.76 |
Return on Networth / Equity (%) | 17.16 | 27.01 | 43.76 | 44.84 | 15.24 |
Return on Capital Employeed (%) | 21.94 | 35.49 | 56.82 | 57.42 | 16.94 |
Return On Assets (%) | 11.30 | 18.23 | 29.11 | 27.20 | 8.17 |
Asset Turnover Ratio (%) | 1.81 | 2.11 | 2.50 | 2.12 | 2.20 |
Current Ratio (X) | 2.23 | 2.41 | 2.48 | 2.20 | 1.66 |
Quick Ratio (X) | 1.69 | 1.64 | 2.05 | 1.68 | 1.17 |
Inventory Turnover Ratio (X) | 5.77 | 6.79 | 8.74 | 5.55 | 6.51 |
Dividend Payout Ratio (NP) (%) | 48.84 | 33.97 | 23.38 | 7.87 | 68.00 |
Dividend Payout Ratio (CP) (%) | 41.68 | 31.06 | 22.00 | 7.27 | 50.33 |
Earning Retention Ratio (%) | 51.16 | 66.03 | 76.62 | 92.13 | 32.00 |
Cash Earning Retention Ratio (%) | 58.32 | 68.94 | 78.00 | 92.73 | 49.67 |
Interest Coverage Ratio (X) | 74.07 | 200.52 | 149.99 | 94.93 | 24.70 |
Interest Coverage Ratio (Post Tax) (X) | 48.98 | 140.30 | 107.29 | 66.68 | 16.81 |
Enterprise Value (Cr.) | 11193.68 | 6625.88 | 8246.18 | 3825.67 | 1074.92 |
EV / Net Operating Revenue (X) | 2.13 | 1.25 | 1.64 | 1.20 | 0.39 |
EV / EBITDA (X) | 20.93 | 9.24 | 8.81 | 5.54 | 6.70 |
MarketCap / Net Operating Revenue (X) | 2.23 | 1.32 | 1.73 | 1.23 | 0.45 |
Retention Ratios (%) | 51.15 | 66.02 | 76.61 | 92.12 | 31.99 |
Price / BV (X) | 5.80 | 3.78 | 5.74 | 3.69 | 1.86 |
Price / Net Operating Revenue (X) | 2.23 | 1.32 | 1.73 | 1.23 | 0.45 |
EarningsYield | 0.02 | 0.07 | 0.07 | 0.12 | 0.08 |
After reviewing the key financial ratios for Supreme Petrochem Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 24, the value is 2.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 2.00.
- For Basic EPS (Rs.), as of Mar 24, the value is 18.43. This value is within the healthy range. It has decreased from 26.49 (Mar 23) to 18.43, marking a decrease of 8.06.
- For Diluted EPS (Rs.), as of Mar 24, the value is 18.43. This value is within the healthy range. It has decreased from 26.49 (Mar 23) to 18.43, marking a decrease of 8.06.
- For Cash EPS (Rs.), as of Mar 24, the value is 21.59. This value is within the healthy range. It has decreased from 28.97 (Mar 23) to 21.59, marking a decrease of 7.38.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 107.38. It has increased from 98.06 (Mar 23) to 107.38, marking an increase of 9.32.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 107.38. It has increased from 98.06 (Mar 23) to 107.38, marking an increase of 9.32.
- For Dividend / Share (Rs.), as of Mar 24, the value is 9.00. This value exceeds the healthy maximum of 3. There is no change compared to the previous period (Mar 23) which recorded 9.00.
- For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 279.37. It has decreased from 281.17 (Mar 23) to 279.37, marking a decrease of 1.80.
- For PBDIT / Share (Rs.), as of Mar 24, the value is 28.45. This value is within the healthy range. It has decreased from 38.13 (Mar 23) to 28.45, marking a decrease of 9.68.
- For PBIT / Share (Rs.), as of Mar 24, the value is 25.28. This value is within the healthy range. It has decreased from 35.66 (Mar 23) to 25.28, marking a decrease of 10.38.
- For PBT / Share (Rs.), as of Mar 24, the value is 24.90. This value is within the healthy range. It has decreased from 35.46 (Mar 23) to 24.90, marking a decrease of 10.56.
- For Net Profit / Share (Rs.), as of Mar 24, the value is 18.43. This value is within the healthy range. It has decreased from 26.49 (Mar 23) to 18.43, marking a decrease of 8.06.
- For PBDIT Margin (%), as of Mar 24, the value is 10.18. This value is within the healthy range. It has decreased from 13.56 (Mar 23) to 10.18, marking a decrease of 3.38.
- For PBIT Margin (%), as of Mar 24, the value is 9.05. This value is below the healthy minimum of 10. It has decreased from 12.68 (Mar 23) to 9.05, marking a decrease of 3.63.
- For PBT Margin (%), as of Mar 24, the value is 8.91. This value is below the healthy minimum of 10. It has decreased from 12.61 (Mar 23) to 8.91, marking a decrease of 3.70.
- For Net Profit Margin (%), as of Mar 24, the value is 6.59. This value is within the healthy range. It has decreased from 9.42 (Mar 23) to 6.59, marking a decrease of 2.83.
- For Return on Networth / Equity (%), as of Mar 24, the value is 17.16. This value is within the healthy range. It has decreased from 27.01 (Mar 23) to 17.16, marking a decrease of 9.85.
- For Return on Capital Employeed (%), as of Mar 24, the value is 21.94. This value is within the healthy range. It has decreased from 35.49 (Mar 23) to 21.94, marking a decrease of 13.55.
- For Return On Assets (%), as of Mar 24, the value is 11.30. This value is within the healthy range. It has decreased from 18.23 (Mar 23) to 11.30, marking a decrease of 6.93.
- For Asset Turnover Ratio (%), as of Mar 24, the value is 1.81. It has decreased from 2.11 (Mar 23) to 1.81, marking a decrease of 0.30.
- For Current Ratio (X), as of Mar 24, the value is 2.23. This value is within the healthy range. It has decreased from 2.41 (Mar 23) to 2.23, marking a decrease of 0.18.
- For Quick Ratio (X), as of Mar 24, the value is 1.69. This value is within the healthy range. It has increased from 1.64 (Mar 23) to 1.69, marking an increase of 0.05.
- For Inventory Turnover Ratio (X), as of Mar 24, the value is 5.77. This value is within the healthy range. It has decreased from 6.79 (Mar 23) to 5.77, marking a decrease of 1.02.
- For Dividend Payout Ratio (NP) (%), as of Mar 24, the value is 48.84. This value is within the healthy range. It has increased from 33.97 (Mar 23) to 48.84, marking an increase of 14.87.
- For Dividend Payout Ratio (CP) (%), as of Mar 24, the value is 41.68. This value is within the healthy range. It has increased from 31.06 (Mar 23) to 41.68, marking an increase of 10.62.
- For Earning Retention Ratio (%), as of Mar 24, the value is 51.16. This value is within the healthy range. It has decreased from 66.03 (Mar 23) to 51.16, marking a decrease of 14.87.
- For Cash Earning Retention Ratio (%), as of Mar 24, the value is 58.32. This value is within the healthy range. It has decreased from 68.94 (Mar 23) to 58.32, marking a decrease of 10.62.
- For Interest Coverage Ratio (X), as of Mar 24, the value is 74.07. This value is within the healthy range. It has decreased from 200.52 (Mar 23) to 74.07, marking a decrease of 126.45.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 24, the value is 48.98. This value is within the healthy range. It has decreased from 140.30 (Mar 23) to 48.98, marking a decrease of 91.32.
- For Enterprise Value (Cr.), as of Mar 24, the value is 11,193.68. It has increased from 6,625.88 (Mar 23) to 11,193.68, marking an increase of 4,567.80.
- For EV / Net Operating Revenue (X), as of Mar 24, the value is 2.13. This value is within the healthy range. It has increased from 1.25 (Mar 23) to 2.13, marking an increase of 0.88.
- For EV / EBITDA (X), as of Mar 24, the value is 20.93. This value exceeds the healthy maximum of 15. It has increased from 9.24 (Mar 23) to 20.93, marking an increase of 11.69.
- For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 2.23. This value is within the healthy range. It has increased from 1.32 (Mar 23) to 2.23, marking an increase of 0.91.
- For Retention Ratios (%), as of Mar 24, the value is 51.15. This value is within the healthy range. It has decreased from 66.02 (Mar 23) to 51.15, marking a decrease of 14.87.
- For Price / BV (X), as of Mar 24, the value is 5.80. This value exceeds the healthy maximum of 3. It has increased from 3.78 (Mar 23) to 5.80, marking an increase of 2.02.
- For Price / Net Operating Revenue (X), as of Mar 24, the value is 2.23. This value is within the healthy range. It has increased from 1.32 (Mar 23) to 2.23, marking an increase of 0.91.
- For EarningsYield, as of Mar 24, the value is 0.02. This value is below the healthy minimum of 5. It has decreased from 0.07 (Mar 23) to 0.02, marking a decrease of 0.05.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation. If you have any questions or need more detailed insights, please feel free to reach out.
Strength and Weakness
Strength | Weakness |
---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Supreme Petrochem Ltd:
- Net Profit Margin: 6.59%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 21.94% (Industry Average ROCE: 12.39%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 17.16% (Industry Average ROE: 8.84%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 48.98
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 1.69
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 26.4 (Industry average Stock P/E: 34.85)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 6.59%
About the Company - Qualitative Analysis
INDUSTRY | ADDRESS | CONTACT |
---|---|---|
Petrochemicals - Polymers | Solitaire Corporate Park, Building No. 11, 5th Floor, 167, Guru Hargovindji Marg, Mumbai Maharashtra 400093 | investorhelpline@spl.co.in http://www.supremepetrochem.com |
Management | |
---|---|
Name | Position Held |
Mr. M P Taparia | Chairperson |
Mr. R Kannan | Director |
Ms. Ameeta Parpia | Director |
Dr. S Sivaram | Director |
Mr. Rajeev M Pandia | Director |
Mr. K V Mujumdar | Director |
Mr. Rajan B Raheja | Director |
Mr. B L Taparia | Director |
Mr. S J Taparia | Director |
Mr. M S Ramachandran | Director |
FAQ
What is the latest intrinsic value of Supreme Petrochem Ltd?
Let's break down Supreme Petrochem Ltd's intrinsic value simply:
We calculate intrinsic value using the PE Ratio Method - comparing the company's current price-to-earnings ratio with its historical average and industry peers. Think of it like checking if a stock is "on sale" compared to its typical pricing.
As of 24 February 2025:
- Calculated Fair Value: ₹403.59
- Current Market Price: ₹584.00
- Variance: 30.89% lower
This suggests Supreme Petrochem Ltd is currently overvalued by 30.89%. For context:
- Market Cap: 10,959 Cr.
- 52-Week Range: 927/556
- Reserves (Sep 2024): ₹2,062 Cr
- Liabilities: 2,995 Cr
Remember: The PE method gives a snapshot based on earnings multiples. While useful for quick comparisons, investors should also consider growth prospects, industry trends, and economic conditions. This calculation assumes historical PE ratios remain relevant - always verify with current market dynamics.
What is the Market Cap of Supreme Petrochem Ltd?
The Market Cap of Supreme Petrochem Ltd is 10,959 Cr..
What is the current Stock Price of Supreme Petrochem Ltd as on 24 February 2025?
The current stock price of Supreme Petrochem Ltd as on 24 February 2025 is ₹584.
What is the High / Low of Supreme Petrochem Ltd stocks in FY 2024-2025?
In FY 2024-2025, the High / Low of Supreme Petrochem Ltd stocks is 927/556.
What is the Stock P/E of Supreme Petrochem Ltd?
The Stock P/E of Supreme Petrochem Ltd is 26.4.
What is the Book Value of Supreme Petrochem Ltd?
The Book Value of Supreme Petrochem Ltd is 112.
What is the Dividend Yield of Supreme Petrochem Ltd?
The Dividend Yield of Supreme Petrochem Ltd is 1.56 %.
What is the ROCE of Supreme Petrochem Ltd?
The ROCE of Supreme Petrochem Ltd is 22.5 %.
What is the ROE of Supreme Petrochem Ltd?
The ROE of Supreme Petrochem Ltd is 16.8 %.
What is the Face Value of Supreme Petrochem Ltd?
The Face Value of Supreme Petrochem Ltd is 2.00.